CCR10 and cancer: Plasmodium infection blocks the TGFβ/CCR10/PI3K/Akt/GSK-3β signaling pathway, thereby inhibiting epithelial–mesenchymal transition (EMT) of the cancer cells and preventing tumor metastasis and recurrence (53, 54).